sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - tilbagevendelse af neuromuskulær blokade induceret af rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex "aspen" 100 mg/ml injektionsvæske, opløsning
aspen pharma trading limited - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
sugammadex "bioglan" 100 mg/ml injektionsvæske, opløsning
bioglan ab - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
sugammadex "qilu" 100 mg/ml injektionsvæske, opløsning
qilu pharma spain s.l. - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
sugammadex "glenmark" 100 mg/ml injektionsvæske, opløsning
glenmark arzneimittel gmbh - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
sugammadex "stada" 100 mg/ml injektionsvæske, opløsning
stada arzneimittel ag - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskulær blokade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex "baxter" 100 mg/ml injektionsvæske, opløsning
baxter holding b.v. - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
foclivia
seqirus s.r.l. - influenzavirusoverfladeantigener, inaktiveret: a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - influenzavacciner - prophylax af influenza i en officielt erklæret pandemisk situation. pandemic influenza vaccine bør anvendes i overensstemmelse med officielle retningslinjer.